Webinar, FAQ Report & Decision Aid | COVID-19 & Neuromuscular Disorders: Ask The Experts
Muscular Dystrophy Canada (MDC) and the Neuromuscular Disease Network for Canada (NMD4C) have received numerous questions about COVID-19 vaccines and how they may uniquely affect people with neuromuscular disorders (NMD).
To address these questions and concerns, MDC & NMD4C assembled a diverse group of neuromuscular, virology, and policy experts to host a webinar with the purpose of answering these topical questions.
From this expert-led webinar, the MDC & NMD4C have developed a frequently asked questions report and decision aid tool as resources to summarize the experts’ answers, and to provide guidance for informed patient decision making.
You can access the Frequently Asked Questions Report, Decision Aid, and webinar recording below!
Report: Frequently Asked Questions – COVID-19 & Neuromuscular Disorders
Decision Aid: I have a NMD, should I get a vaccine for COVID-19
We are excited to have the following experts address questions about NMDs, COVID-19 and vaccines:
- Dr. Hans Katzberg, adult neuromuscular specialist and NMD researcher
- Dr. Hanns Lochmuller, pediatric neuromuscular specialist and NMD researcher
- Dr. Reshma Amin, respirologist and NMD researcher
- Dr. Megan Bettle, Director of the COVID-19 Regulatory Response Team at Health Canada / Government of Canada
- Dr. Allison McGeer, Infectious Disease Specialist and COVID-19 researcher
- Dr. Anne Pham-Huy, Infectious Disease Specialist and Chair of Immunize Canada
Read next...
Discover Neuromuscular Talent Across Canada
The NMD4C Neuromuscular Talent Pool is now live with new trainees! We invite supervisors and research groups to explore the Talent Pool to identify candidates whose skills, experience, and interests align with your work and upcoming positions. Trainees interested in being included in the Neuromuscular Talent Pool can register by completing the short form, uploading a CV and brief personal statement outlining their experience, interests, and career goals. For more information and to access the Talent Pool, please visit our website.
Join Us at the 2026 NMD4C Annual Meeting on 25 September
The 2026 NMD4C Annual Meeting will take place in Calgary on Friday, September 25, 2026. The agenda will feature a brief network update, trainee and early-career recognitions, flash talks, a health economics research showcase, and a series of cross‑disciplinary and parallel clinical/pre‑clinical discussion sessions to explore key topics, including advocacy and therapy access, strategies to sustain and strengthen pre-clinical programs, and network sustainability and strategic planning.
Introducing Our New SOP on Skeletal Muscle Fiber Typing
We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Skeletal Muscle Fiber Typing & Cross-Sectional Area Analysis using Immunofluorescence Staining for Mice,” developed by from our Basic Science Trainee Committee (BSTC) member Shatha Atieh, Phd Student at uOttawa. This SOP aims to provide a comprehensive, step-by-step protocol for staining and analyzing skeletal muscle fibers from any muscle group in various mouse models. This new SOP provides detailed methods for immunofluorescence‑based fiber typing using MyHC‑I, MyHC‑IIA, MyHC‑IIB, and laminin, enabling accurate assessment of fiber‑type composition and cross‑sectional area (CSA).